case rePort J Neurosurg Pediatr 15:301-305, 2015 P ediatric stroke is an uncommon occurrence, with an estimated incidence of 2.3-13 per 100,000 children. 13 Although rare, the incidence appears to be rising. Acute ischemic stroke (AIS) is associated with significant morbidity and mortality; up to 50%-80% of survivors have neurological deficits, most commonly hemiparesis, but also long-term neuropsychiatric and behavioral issues. 4 The etiology of AIS in the pediatric population differs from that in adults because pediatric stroke is often related to congenital disease or trauma as opposed to acquired cardiovascular complications.
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Children experiencing severe neurological deficit due to acute ischemic stroke may benefit from endovascular intervention. The authors describe the use of mechanical thrombectomy in the treatment of embolic occlusion secondary to an atrial myxoma in a pediatric patient. This case involved an 11-year-old boy with a history notable for Raynaud syndrome and a distal extremity rash who presented to the emergency department with dense hemiparesis secondary to thromboembolic occlusion of the M 1 segment of the middle cerebral artery. Following mechanical thrombectomy, the patient's pediatric National Institutes of Health Stroke Scale score improved from a 16 to a 7. In the setting of acute pediatric stroke due to atrial myxoma emboli, mechanical thrombectomy may be a first-line therapy.
tery (MCA) (Fig. 2 right) . In line with current guidelines for pediatric AIS, he was not eligible for intravenous (IV) recombinant tissue plasminogen activator (r-tPA) therapy due to risk for significant bleeding, and instead underwent emergency endovascular surgery for clot retrieval at 3 hours and 3 minutes after initial onset of symptoms.
Endovascular Management
A diagnostic cerebral angiogram was performed under general endotracheal anesthesia. Selective catheterization of the right internal carotid artery confirmed complete occlusion of the right M 1 segment of the MCA, as well as occlusion of a fetal posterior communicating artery (PCoA) (Fig. 3) .
Mechanical thrombectomy was initially attempted using the Trevo clot retrieval system (Concentric Medical, Inc.), with 3 passes in the MCA; however, only partial clot retrieval was possible, and the M 1 segment remained occluded (images not shown). The thrombectomy was particularly difficult because of significant clot resistance; the retrieved portions of the clot were unusual and appeared fatty, gelatinous, and friable. Complete revascularization of the proximal M 1 segment with thrombectomy was achieved using the Penumbra 041 System (Penumbra, Inc.). Small distal MCA emboli and fetal PCoA emboli were noted after restoration of flow in the proximal MCA (Fig. 4) , and the Penumbra System 026 was used to revascularize the distal branches of the MCA as well as the fetal PCoA. In summary, we achieved complete revascularization of the M 1 segment of the MCA, the fetal PCoA, and approximately 90%-95% of all distal branches; only 1 small distal MCA branch remained stagnant at the end of the procedure and was in a territory no longer amenable to thrombectomy (Fig. 5 ).
Postoperative Course and Follow-Up
In the postoperative period the patient was noted to have some improvement, with movement in the left upper extremity by withdrawing to painful stimuli, but initially no movement was appreciated in the left lower extremity. As part of his stroke workup, the patient was started on aspirin, and echocardiography was performed on hospital Day 2, which revealed a 4 × 3-cm, pedunculated, raggededged, mobile mass attached to the lower one-third of the left side of the atrial septum, prolapsing into and across the mitral valve. The cardiac surgeons evaluated the patient for this large left atrial mass and determined that it was consistent with a myxoma; he was taken to the OR urgently for removal of the mass to prevent additional embolic events. The specimen was sent to the pathology laboratory, which confirmed the diagnosis of atrial myxoma (Fig. 6) .
By hospital Day 3, the patient had significant improvement in his left lower-extremity function and modest improvement in the left facial droop. He had continued improvement over the next week and was ambulatory by hospital Day 6. By hospital Day 9, the patient's NIHSS score had been reduced to a 7, and he regained significant strength of 4 to 4+/5 on the left side, with some apraxia. He was also functionally independent, with a modified Rankin Scale score of 1, and was discharged the following day for inpatient rehabilitation.
discussion
Primary cardiac tumors are extremely rare in the pediatric population, with a prevalence of 0.0017-0.28 in autopsy series. 15, 17 Although atrial myxomas are only the third most common form of cardiac tumors in children, these are of particular interest due to their autosomal dominant inheritance pattern and potential to generate AIS.
3,18 Similar to our patient, a number of previous case reports indicate that AIS and neurological deficits secondary to embolic occlusion are the most common complications of atrial myxoma. 1, 6 In addition, as seen during the thrombectomy of our patient, emboli secondary to atrial myxoma are particularly problematic due to their friable, gelatinous, and/or villous composition, which may impede optimal response to traditional embolic treatments. 7, 14 While there are clear guidelines for the treatment of stroke in adults, several barriers have prevented the development of stroke guidelines in the pediatric population. Primarily, the low incidence of stroke in children delays diagnosis and prevents clinical trials that address effective treatment. 2 Contrary to adult guidelines for AIS, there are no recommendations for IV r-tPA in the pediatric setting. The American College of Chest Physicians recommends anticoagulant therapy with low-molecular-weight heparin or vitamin K antagonist for 3 months in children suffering from AIS of cardioembolic origin. 11, 16 Given the lack of approved therapy for the treatment of thromboembolic stroke in pediatric patients, more studies are necessary to determine the most effective treatments of stroke in the pediatric population. Although the Thrombolysis in Pediatric Stroke (TIPS) trial was designed to determine the efficacy of IV r-tPA in children, this modality may be ineffective in patients with stroke-related atrial myxoma because the course of presentation is often deceiving, extending time to diagnosis outside the therapeutic window. Atrial myxomas are also associated with aneurysms, a contraindication to IV r-tPA and, if the myxoma itself embolizes, it is not treatable by thrombolysis. 9, 10 Together, these potential complications support mechanical thrombectomy as an alternative in the treatment of cerebral embolism secondary to atrial myxoma. Mechanical thrombectomy has been described in a number of pediatric case reports as treatment for occlusive AIS. 8 In previously documented cases in the literature, 19 pediatric patients were treated within a mean time of 17.6 hours (range 3-44 hours) with a variety of techniques and devices. In cases of documented complete recanalization following successful mechanical thrombectomy (8 of 15 reported cases), there has been a trend toward favoring the use of the Penumbra device (50%; 4 of 8 cases) over that of the Solitaire device (25%; 2 of 8 cases), although there is still no consensus to date.
8,19
Despite these prior reports, none have addressed the use of mechanical thrombectomy in the management of embolic thrombi of atrial myxomatous origin. Only 1 case report describes mechanical thrombectomy in retrieval of clot secondary to atrial myxoma in an adult present- ing with left MCA syndrome. Similar to our case, GarciaPtacek et al. 7 describe clot resistance requiring multiple passes for complete removal during thrombectomy. In addition, in the adult cases variability in success and subsequent clinical outcome have been described, further highlighting the unique complications posed by atrial myxoma emboli secondary to clot heterogeneity. Lee et al. also suggest that mechanical thrombectomy may be superior to IV r-tPA in the setting of atrial myxoma emboli due to their association with microaneurysms. 12 Together, prior evidence in adults and the pediatric case reported here support mechanical thrombectomy as a treatment modality for cerebral emboli secondary to atrial myxoma.
conclusions
This case report provides support for acute mechanical thrombectomy as a safe and effective treatment for occlusive stroke secondary to pediatric atrial myxoma emboli. More studies are needed to determine the benefit of mechanical thrombectomy, particularly in the setting of atrial myxoma, in which aneurysms and heterogeneic clots may preclude the use of traditional fibrinolytic or anticoagulation approaches.
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